ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 147 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,722,007 | -14.4% | 523,280 | -17.0% | 12.30% | -25.7% |
| Q2 2023 | $12,525,651 | +1.3% | 630,380 | -12.7% | 16.55% | +18.3% |
| Q1 2023 | $12,369,230 | -12.5% | 722,080 | 0.0% | 13.99% | +3.8% |
| Q4 2022 | $14,131,106 | +33.0% | 722,080 | +8.4% | 13.47% | +21.4% |
| Q3 2022 | $10,627,000 | +7.9% | 665,880 | -7.0% | 11.09% | +0.5% |
| Q2 2022 | $9,851,000 | -13.2% | 715,880 | 0.0% | 11.04% | +5.8% |
| Q1 2022 | $11,354,000 | +5.0% | 715,880 | +44.5% | 10.44% | +23.6% |
| Q4 2021 | $10,812,000 | – | 495,280 | – | 8.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 16,812,491 | $234,534,000 | 10.10% |
| TANG CAPITAL MANAGEMENT LLC | 2,965,485 | $41,369,000 | 5.81% |
| Ghost Tree Capital, LLC | 650,000 | $9,068,000 | 2.40% |
| Boxer Capital, LLC | 1,466,051 | $20,451,000 | 1.39% |
| Vivo Capital, LLC | 860,648 | $12,006,000 | 1.09% |
| Samsara BioCapital, LLC | 128,197 | $1,788,000 | 1.03% |
| Cormorant Asset Management, LP | 1,568,550 | $21,881,000 | 1.02% |
| Perceptive Advisors | 2,189,010 | $30,537,000 | 0.80% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,677,367 | $23,399,000 | 0.74% |
| Eventide Asset Management | 1,415,000 | $19,739,000 | 0.64% |